Among the populations of Tonga and Western Samoa, serum antibodies against human immunodeficiency virus or hemorrhagic fever with renal syndrome virus were not detected (0/904 and 0/192). No serum samples were considered to be positive for antibody against human T-cell lymphotropic virus type 1 (0/527). Hepatitis B antigen and antibody were found in 4% (8/192) and 47% (90/192), respectively.
INTRODUCTION

Western
Samoa and the Kingdom of Tonga are parts of the South Pacific
Islands. These islands were thought to be untouched by a new viral disease, such as human immunodeficiency virus (HIV) infection, because of being isolated from other countries. Today, we cannot deny the invasion of HIV infection in these countries through foreign tourists and repatriates. In mid-1987, a Tongan national returned from the United States with AIDS and was nursed in a hospital in Tonga until his death a short time later (1). We had an opportunity to visit these countries as consultants for WHO's Special Programme on AIDS. Our project was to work with the governments of these countries to formulate a short-term plan for AIDS prevention and control. During our visits, we were able to obtain blood samples. We examined these samples for not only antibodies against HIV and human T-cell lymphotropic virus type 1 (HTLV-1) but also those against hepatitis B virus surface (HBs) antigen, Chlamydia trachomatis and C. psittaci, and hemorrhagic fever with renal syndrome virus (HFRSV). We examined also for HBs antigen. Here we report the results of our examinations and discuss prevention of the infection on the Islands.
MATERIALS AND METHODS
Sera: Seven hundred and twelve Tongan adult sera were collected at health centers in 1985 in the field study of hepatitis B. One hundred and ninety-two Western Samoan sera were obtained from adolescents (10-20 years old) and adults who visited the National Hospital in 1988. The sera were randomly collected from the clinics.
Studies were carried out mainly on Western Samoan sera because the. volume of samples from Tonga was not sufficient for all the examinations.
HIV antibody: Enzyme immunoassay (EIA) test kits (2) from Abbott company were used for the Tongan sera following the manufacturer's instruction. The gelatin particle agglutination (PA) test with the kit from Fuji Rebio Inc. was conducted on Western Samoan sera following the manufacturer's instruction (3). Fluorescence antibody (FA) method and western blot (WB) analysis were conducted as in the previous reports (4,5). Persistently HIV-1-infected MOLT4/KB-1 cells propagated in our laboratory were used as FA and WB virus antigens.
HTLV-1 antibody: The PA test kit from Fuji Rebio was used for screening of the HTLV-1 antibody (6) . Persistenty HTLV-1-infected MT1 and TCL-Kan cells were used for the FA method and WB analysis, respectively, with affinitypurified peroxidase-conjugated goat anti-human IgG (Pel Freeze Co., Rogers, AR) (5,7) for the confirmatory test. Samples with both gag and env proteins detectable by WB were considered to be HTLV-1-antibody positive. Those with only gag protein detectable as equivocal, while those with neither gag nor env protein as HTLV-1-antibody negative. The samples positive by both FA and WB were considered to be indisputably positive for HTLV-1 antibody.
HBs antigen and HBs antibody: HBs antigen and HBs antibody test kits were kindly given to us by the Institute of Immunology Co. Ltd., Tokyo, Japan. The passive hemagglutination test for HBs antibody and the reverse passive hemagglutination test for HBs antigen (8) were conducted following the manufacturer's instruction (9) .
Antibodies against C. trachomatis and C. psittaci: IgG and IgA antibodies against C. trachomatis and C. psittaci were examined by the microplate FA method provided by the Denkaseiken Co. Ltd., Tokyo, Japan (10).
HFRSV antibody: HFRSV IgG antibody was detected by the FA method with HFRSV (SR-11strain)-infected Vero E6 cells (11) .
RESULTS
HIV Antibody
The seven hundred and twelve Tongan sera were all HIV negative by enzyme immunoassay.
The one hundred and ninety-two Western Samoan sera were all negative by PA.
HTLV-1 Antibody
Eleven (3.3%) of the 335 Tongan sera and five (2.6%) of the 192 Western Samoan sera were positive by PA. HTLV-1 antibody titers in positive sera were between 256 and 16 (Table I) . Positive sera by PA were further examined by FA and WB. All 16 sera were negative by FA, while one serum was negative by WB.
The other 15 sera showed an equivocal result by WB (Table II) . We concluded all sera were HTLV-1 negative. (Table IV) . Chlamydia trachomatis infection causes pneumonia, conjunctivitis, sexually transmitted diseases and so on in adults and infants (17, 18) . Almost half of the Samoan sera had positive IgG antibody to both C. trachomatis and C. psittaci. About 10% of the sera showed IgA antibody, which means active infection (19) . In our experiments, quantitations of IgA and IgG antibodies were not done for either C. trachomatis or C. psittaci, but our data indicate a high incidence of chlamydial infection in the South Pacific Islands.
Sexually transmitted diseases, including C. trachomatis, frequently precede to HIV infection (20) . Our data suggest that, if HIV infection invades these islands, it may spread readily among the people.
HFRS is a serious infection in the northern parts of Asia and Europe. It is estimated that 500 to 1,000 cases occur annually in the Soviet Union and in the Republic of Korea. Mortality by the Far Eastern type of HFRSV has decreased from 10 to 15% to around 5% (21, 22) . This is due primarily to improved managements of patients and supportive cares and to the introduction of renal dialysis. Antibodies against HFRSV were detected in humans and urban rats in Age-and sex-specific incidences of serum antibodies against HIV , HTLV-1, HBV, HFRSV and Chlamydia were not determined in our study of adolescents and adults. We will examine infants and children in the future . 
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